The year 2019 has been a busy year for global pharma and biotech companies involved in M&A, option & licensing agreements and gaining approvals. Our team has compiled a list […]readmore
Tags : Evolus
Regulatory
Evolus’ Jeuveau (prabotulinumtoxinA-xvfs) Receives FDA Approval for Moderate-to-Severe Glabellar Lines
Shots: The approval is based on four P-III trials including two (EV-001 & EV-002) US trials and European & Canadian i.e TRANSPARENCY study results assessing Jeuveau vs PBO & Botox […]readmore